美国大型马拉松期间急诊延误与死亡率
该研究分析2002至2012年美国11个举办大型马拉松城市的医保数据,比较马拉松当日、前后5周同一星期几及马拉松周边未受影响区域住院的急性心肌梗死或心脏骤停患者30天死亡率。马拉松当日受影响区域30天死亡率为28.2%(1145例住院中323例死亡),非马拉松日为24.9%(11074例住院中2757例死亡),绝对风险差3.3个百分点(95%CI 0.7至6.0,P=0.01),相对风险差13.3%。救护车从现场到医院转运时间在午前马拉松日比非马拉松日延长4.4分钟(相对差异32.1%,P=0.005),晚间及未受影响区域未见延误。
要点
- 马拉松当日受影响区域住院的急性心梗或心脏骤停患者30天死亡率为28.2%,非马拉松日为24.9%,绝对风险差3.3个百分点(95%CI 0.7至6.0)。
- 午前救护车现场到医院转运时间在马拉松日比非马拉松日延长4.4分钟(相对差异32.1%,P=0.005)。
- 晚间道路重新开放后及马拉松未受影响区域未发现转运延误。
- 调整协变量后及纳入5种以上慢性病患者的分析中,马拉松日死亡率升高模式持续存在。
- 患者住院地点及院内治疗未见显著差异。
适用人群与场景
- 美国11个举办大型马拉松城市的医保受益人(≥65岁),因急性心肌梗死或心脏骤停住院。
- 分析场景为马拉松当日受影响区域,并与前后5周同一星期几及马拉松周边未受影响区域比较。
研究设计与关键结果
- 研究类型为医保数据回顾性分析,纳入2002至2012年美国11个城市大型马拉松期间急性心肌梗死或心脏骤停住院的医保受益人(≥65岁)。
- 马拉松日与非马拉松日每日住院频率相似(每城市平均住院数分别为10.6和10.5,P=0.71),住院患者特征也相似。
- 马拉松日受影响区域未调整30天死亡率为28.2%(1145例住院中323例死亡),非马拉松日为24.9%(11074例住院中2757例死亡),绝对风险差3.3个百分点(95%CI 0.7至6.0,P=0.01),相对风险差13.3%。
- 调整协变量后及纳入5种以上慢性病患者(该群体不太可能因参加马拉松而住院)的分析中,该模式持续存在。
- 患者住院地点及院内治疗未见显著差异。
- 午前救护车现场到医院转运时间在马拉松日比非马拉松日延长4.4分钟(相对差异32.1%,P=0.005)。
- 晚间及马拉松未受影响区域未发现转运延误。
证据类型、等级与局限
- 证据类型为基于医保数据的回顾性分析,并分析了全国救护车转运登记数据。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,马拉松当日受影响医院收治的急性心肌梗死或心脏骤停医保受益人午前救护车转运时间延长4.4分钟且30天死亡率高于非马拉松日住院者。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Large marathons frequently involve widespread road closures and infrastructure disruptions, which may create delays in emergency care for nonparticipants with acute medical conditions who live in proximity to marathon routes.
METHODS: We analyzed Medicare data on hospitalizations for acute myocardial infarction or cardiac arrest among Medicare beneficiaries (≥65 years of age) in 11 U.S. cities that were hosting major marathons during the period from 2002 through 2012 and compared 30-day mortality among the beneficiaries who were hospitalized on the date of a marathon, those who were hospitalized on the same day of the week as the day of the marathon in the 5 weeks before or the 5 weeks after the marathon, and those who were hospitalized on the same day as the marathon but in surrounding ZIP Code areas unaffected by the marathon. We also analyzed data from a national registry of ambulance transports and investigated whether ambulance transports occurring before noon in marathon-affected areas (when road closures are likely) had longer scene-to-hospital transport times than on nonmarathon dates. We also compared transport times on marathon dates with those on nonmarathon dates in these same areas during evenings (when roads were reopened) and in areas unaffected by the marathon.
RESULTS: The daily frequency of hospitalizations was similar on marathon and nonmarathon dates (mean number of hospitalizations per city, 10.6 and 10.5, respectively; P=0.71); the characteristics of the beneficiaries hospitalized on marathon and nonmarathon dates were also similar. Unadjusted 30-day mortality in marathon-affected areas on marathon dates was 28.2% (323 deaths in 1145 hospitalizations) as compared with 24.9% (2757 deaths in 11,074 hospitalizations) on nonmarathon dates (absolute risk difference, 3.3 percentage points; 95% confidence interval, 0.7 to 6.0; P=0.01; relative risk difference, 13.3%). This pattern persisted after adjustment for covariates and in an analysis that included beneficiaries who had five or more chronic medical conditions (a group that is unlikely to be hospitalized because of marathon participation). No significant differences were found with respect to where patients were hospitalized or the treatments they received in the hospital. Ambulance scene-to-hospital transport times for pickups before noon were 4.4 minutes longer on marathon dates than on nonmarathon dates (relative difference, 32.1%; P=0.005). No delays were found in evenings or in marathon-unaffected areas.
CONCLUSIONS: Medicare beneficiaries who were admitted to marathon-affected hospitals with acute myocardial infarction or cardiac arrest on marathon dates had longer ambulance transport times before noon (4.4 minutes longer) and higher 30-day mortality than beneficiaries who were hospitalized on nonmarathon dates. (Funded by the National Institutes of Health.).
参考来源
- Jena AB, Mann NC, Wedlund LN, et al. Delays in Emergency Care and Mortality during Major U.S. Marathons. N Engl J Med. 2017. PMID: 28402772. doi:10.1056/NEJMsa1614073
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。